PrimeRFP SCOUT · Federal Contract Recompete Brief

HDTRA124C0014ORAL BROAD spectrum antiviral tlr7 agonist — Primmune Therapeutics, Inc

Primmune Therapeutics, Inc holds $11.0M across 1 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Aug 31, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Threat Reduction Agency

Awarding office

Primmune Therapeutics, Inc

Recipient

Aug 31, 2026

PoP end

$11.2M

Obligated

$23.1M

Potential

541715

NAICS

AC33

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Primmune Therapeutics, Inc — $90

Contract facts

NONE

Contract numberHDTRA124C0014

Also listed asHDTRA1-24-C-0014

AgencyDefense Threat Reduction Agency

Awarding officeDefense Threat Reduction Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentPrimmune Therapeutics, Inc

CAGE8J8L4

UEIRCE3KW671H83

NAICS541715

PSCAC33

Place of performanceCARLSBAD CA

Pricing typeCost Plus Fixed Fee

Extent competedFull And Open Competition

Related solicitationHDTRA117S0002

PoP startJan 30, 2024

PoP end (current)Aug 31, 2026

PoP end (w/ options)Dec 31, 2027

Obligated$11.2M

Current value$11.3M

Potential value$23.1M

ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER is a federal NONE award for Defense Threat Reduction Agency held by Primmune Therapeutics, Inc. Estimated value $23.1M ($11.2M obligated). Current period of performance ends Aug 31, 2026 (potential Dec 31, 2027). Last award drew 1 bidder. Place of performance: CARLSBAD CA. Related solicitation HDTRA117S0002.

ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER

Recompete timing

Public

● Past PoP end (7 days ago)

Current PoP ended Aug 31, 2026 (7 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Primmune Therapeutics, Inc — $11.0M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$11.0M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HDTRA124C0014?

HDTRA124C0014 (ORAL BROAD spectrum antiviral tlr7 agonist) is a Defense Threat Reduction Agency award with a potential value of $23.1M, currently held by Primmune Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HDTRA1-24-C-0014?

HDTRA1-24-C-0014 is the dashed form of PIID HDTRA124C0014 (ORAL BROAD spectrum antiviral tlr7 agonist), held by Primmune Therapeutics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HDTRA124C0014?

Defense Threat Reduction Agency awarded HDTRA124C0014 to Primmune Therapeutics, Inc (potential $23.1M).

Who is the incumbent on HDTRA124C0014?

Primmune Therapeutics, Inc is the incumbent with $11.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2026.

When does Primmune Therapeutics, Inc’s HDTRA124C0014 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HDTRA124C0014 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 20, 2026